Latest News and Press Releases

JM AB has in a press release announced the final acceptance of the redemption offer. Due to the redemption offer, 1:16 settlement SEK 180 in JM AB, OMX Nordic Exchange Stockholm will act and adjust JM...

Novo Nordisk today announced the decision to discontinue the phase 3 clinical trial with NovoSeven® for the treatment of bleeding in patients with severe trauma. The decision was made based on the...

På grund af en observeret lavere mortalitet end forventet i den samlede forsøgsgruppe (omkring 10% i fase 3-forsøget totalt mod mere end 25% i fase 2-forsøget) blev der gennemført en futilitetsanalyse...

Novo Nordisk discontinues phase 3 clinical trial with NovoSeven® in trauma Novo Nordisk today announced the decision to discontinue the phase 3 clinical trial with NovoSeven® for the treatment of...

Novo Nordisk meddelte i dag, at virksomheden har besluttet at indstille det kliniske fase 3-forsøg med NovoSeven® til behandling af blødninger hos patienter med svære traumer. Beslutningen er...

JM har i ett pressmeddelande offentliggjort den slutgiltliga sammanräkningen av inlösenerbjudandet. Med anledning av inlösenerbjudandet, 1:16 likvid 180 kr kommer OMX Nordic Exchange Stockholm att...

Danware A/S - transfer to the observation list OMX Nordic Exchange Copenhagen has transferred the ISIN below to the observation list today: ...

RE: THE EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS The Extraordinary General Meeting of TEO LT, AB (code 1212 15434, registered address: Savanorių ave. 28, Vilnius, Lithuania) Shareholders...

Sven Thorngren, EOS Russia's CEO and co-founder, has increased his shareholding in the company Sven Thorngren, EOS Russia's CEO and co-founder, has increased his shareholding in the company by 10,000...

Sven Thorngren, Verkställande direktör och en av grundarna av EOS Russia, har utökat sitt aktieinnehav i EOS Russia Sven Thorngren, Verkställande direktör och en av grundarna av EOS Russia,...